Funded by the Global Fund to fight AIDS, TB and malaria, the UNDP “Effective HIV and TB and control in the Kyrgyz Republic” project aims at reducing the burden of HIV and TB in the Kyrgyz Republic by providing timely and quality prevention, diagnosis and treatment. The project works to strengthen the health care system in the country, and recently has also adapted to help fight the new Covid-19 pandemic.
HIV: The project purchases quality treatment for people living with HIV. The project works with 19 NGOs and 4 organizations to prevent HIV in key groups of the population (LGBT, sex workers, people who inject drugs, people living with HIV). This includes providing consultations and support, free and regular rapid HIV testing, prevention material (condoms, syringes) and methadone treatment.
TB: The project purchases quality drugs and injections for the treatment of M/XDR-TB (multidrug or extensively drug-resistant tuberculosis), enabling the system to provide free treatment for all patients in Kyrgyzstan. It ensures timely ordering and delivery of drugs, safe storing and distribution. The project also provides case managers to support patients on treatment for M/XDR-TB and reduce the number of patients interrupting their treatment.
Covid-19: The project is quickly adapting to the Covid-19 pandemic, purchasing necessary equipment for the health care system and helping partners adapt their response to HIV and TB in this context.
- In 2019, the project purchased 80% of drugs for ART treatment
- In the first semester of 2019, 14783 people were tested for HIV with rapid test and 29045 people were consulted and given HIV prevention packages among key population groups
- More than 1000 patients, who previously injected drugs, are taking methadone treatment
- 59 children participated in the HIV summer camp in 2019
- 472 children with HIV and their families benefited from monthly motivational payments in 2019
- In 2019, 616 children were scanned for TB through MRT. 157 of them were diagnosed with TB and started on the adequate treatment
- The project purchases MDR/XDR - TB treatment for around 1200 patients each year
- Nearly 1400 TB patients benefit from support of case managers and monthly motivational treatment
- In Bishkek, the number of TB patients lost to follow up dropped from more than 20% to around 3%.
- All HIV and TB patients have access to free, timely and quality treatment
- More than 90% out of all RR/MDR/XDR TB cases are enrolled on treatment, annually nearly 1400 patients with RR/MDR/XDR TB start treatment.
- The number of TB patients lost to follow up within the first 6 months of treatment is still <10%
- >70% confirmed RR/MDR TB cases are tested for susceptibility to any fluoroquinolone and any second-line injectable drug
- The number of new HIV infections, especially among key populations, is reduced by 50% by 2021 compared to 2015
- 90% of people living with HIV receive antiretroviral therapy (ART) and viral load suppression is acheived in 90% of people receiving ART by 2021
Start date: July 2018
Projected end date: December 2020
Geographic coverage: Kyrgyz Republic
Subject area: Health
Project coordinator: Itana Labovic
Partners: Ministry of Health of the Kyrgyz Republic, Republican AIDS Center, National TB Center, Republican Center for Addictions, NGOs, Regional AIDS and TB centers
Funding Source: The Global Fund to fight AIDS, TB and malaria
2018 - $7,727,877
2019 - $7,985,249
2020 - $5,246,698